References
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:https://doi.org/10.3322/caac.21262.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin. 2020;70(1):7–30. doi:https://doi.org/10.3322/caac.21590.
- Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404–23. doi:https://doi.org/10.3322/caac.21631.
- Shigehara K, Sasagawa T, Kawaguchi S, Nakashima T, Shimamura M, Maeda Y, et al. Etiologic role of human papillomavirus infection in bladder carcinoma. Cancer. 2011;117(10):2067–76. doi:https://doi.org/10.1002/cncr.25777.
- Miyamoto DT, Mouw KW, Feng FY, Shipley WU, Efstathiou JA. Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer. The Lancet. Oncology. 2018;19(12):e683–e695. doi:https://doi.org/10.1016/S1470-2045(18)30693-4.
- Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324(19):1980–91. doi:https://doi.org/10.1001/jama.2020.17598.
- Abufaraj M, Dalbagni G, Daneshmand S, Horenblas S, Kamat AM, Kanzaki R, et al. The role of surgery in metastatic bladder cancer: a systematic review. Eur Urol. 2018;73(4):543–57. doi:https://doi.org/10.1016/j.eururo.2017.09.030.
- Liu X, Lieberman J. A mechanistic understanding of pyroptosis: the fiery death triggered by invasive infection. Adv Immunol. 2017;135:81–117. https://doi.org/10.1016/bs.ai.2017.02.002.
- Zhivaki D, Kagan JC. NLRP3 inflammasomes that induce antitumor immunity. Trends Immunol. 2021;42(7):575–89. doi:https://doi.org/10.1016/j.it.2021.05.001.
- Lu X, Guo T, Zhang X. Pyroptosis in cancer: friend or foe? Cancers. 2021;13(14):3620. doi:https://doi.org/10.3390/cancers13143620.
- Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42(4):245–54. doi:https://doi.org/10.1016/j.tibs.2016.10.004.
- Li L, Jiang M, Qi L, Wu Y, Song D, Gan J, et al. Pyroptosis, a new bridge to tumor immunity. Cancer Sci. 2021;112(10):3979–94. doi:https://doi.org/10.1111/cas.15059.
- Chu LH, Indramohan M, Ratsimandresy RA, Gangopadhyay A, Morris EP, Monack DM, et al. The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages. Nat Commun. 2018;9(1):996. https://doi.org/10.1038/s41467-018-03409-3.
- Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99–103. doi:https://doi.org/10.1038/nature22393.
- Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579(7799):415–20. doi:https://doi.org/10.1038/s41586-020-2071-9.
- Tan Y, Sun R, Liu L, Yang D, Xiang Q, Li L, et al. Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer. Theranostics. 2021;11(11):5214–31. doi:https://doi.org/10.7150/thno.58322.
- Yuan R, Zhao W, Wang QQ, He J, Han S, Gao H, et al. Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis. Pharmacol Res. 2021;170:105748. doi:https://doi.org/10.1016/j.phrs.2021.105748.
- Gao J, Qiu X, Xi G, Liu H, Zhang F, Lv T, Song Y. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer. Oncol Rep. 2018;40(4):1971–84. doi:https://doi.org/10.3892/or.2018.6634.
- Zhang CC, Li CG, Wang YF, Xu LH, He XH, Zeng QZ, et al. Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation. Apoptosis. 2019;24(3–4):312–25. doi:https://doi.org/10.1007/s10495-019-01515-1.
- Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nature reviews. Cancer. 2019;19(4):197–214. doi:https://doi.org/10.1038/s41568-019-0123-y.
- Xia X, Wang X, Cheng Z, Qin W, Lei L, Jiang J, Hu J. The role of pyroptosis in cancer: pro-cancer or pro-“host”? Cell Death Dis. 2019;10(9):650. doi:https://doi.org/10.1038/s41419-019-1883-8.
- Wang B, Yin Q. AIM2 inflammasome activation and regulation: a structural perspective. J Struct Biol. 2017;200(3):279–82. doi:https://doi.org/10.1016/j.jsb.2017.08.001.
- Tang G, Duan F, Li W, Wang Y, Zeng C, Hu J, et al. Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE–/– mice. Biomed Pharmacother. 2019;119:109410. doi:https://doi.org/10.1016/j.biopha.2019.109410.
- Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011;39(Database issue):D561–D568. doi:https://doi.org/10.1093/nar/gkq973.
- Tibshirani R. The lasso method for variable selection in the Cox model. Statist Med. 1997;16(4):385–95. doi:https://doi.org/10.1002/(sici)1097-0258(19970228)16:4 < 385::aid-sim380 > 3.0.co;2-3.
- Riester M, Taylor JM, Feifer A, Koppie T, Rosenberg JE, Downey RJ, et al. Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin Cancer Res. 2012;18(5):1323–33. doi:https://doi.org/10.1158/1078-0432.CCR-11-2271.
- Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110. https://doi.org/10.1158/0008-5472.CAN-17-0307.
- Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160(1–2):48–61. doi:https://doi.org/10.1016/j.cell.2014.12.033.
- Li Y, Huang H, Liu B, Zhang Y, Pan X, Yu XY, et al. Inflammasomes as therapeutic targets in human diseases. Signal Transduct Target Ther. 2021;6(1):247. https://doi.org/10.1038/s41392-021-00650-z.
- Wu D, Wang S, Yu G, Chen X. Cell death mediated by the pyroptosis pathway with the aid of nanotechnology: prospects for cancer therapy. Angew Chem Int Ed Engl. 2021;60(15):8018–34. doi:https://doi.org/10.1002/anie.202010281.
- Li YK, Chen JG, Wang F. The emerging roles of absent in melanoma 2 (AIM2) inflammasome in central nervous system disorders. Neurochem Int. 2021;149:105122. doi:https://doi.org/10.1016/j.neuint.2021.105122.
- Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature. 2009;458(7237):509–13. doi:https://doi.org/10.1038/nature07710.
- Li Y, Wang W, Li A, Huang W, Chen S, Han F, Wang L. Dihydroartemisinin induces pyroptosis by promoting the AIM2/caspase-3/DFNA5 axis in breast cancer cells. Chem Biol Interact. 2021;340:109434. doi:https://doi.org/10.1016/j.cbi.2021.109434.
- Zhou Z, He H, Wang K, Shi X, Wang Y, Su Y, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020;368(6494):eaaz7548. doi:https://doi.org/10.1126/science.aaz7548.
- He H, Yi L, Zhang B, Yan B, Xiao M, Ren J, et al. USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway. Int J Biol Sci. 2021;17(10):2417–2429. doi:https://doi.org/10.7150/ijbs.54442.
- Kayagaki N, Stowe IB, Lee BL, O’Rourke K, Anderson K, Warming S, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526(7575):666–71. doi:https://doi.org/10.1038/nature15541.
- Jiang S, Gu H, Zhao Y, Sun L. Teleost gasdermin E is cleaved by caspase 1, 3, and 7 and induces pyroptosis. J Immunol. 2019;203(5):1369–82. doi:https://doi.org/10.4049/jimmunol.1900383.
- Chen X, He WT, Hu L, Li J, Fang Y, Wang X, et al. Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 2016;26(9):1007–20. doi:https://doi.org/10.1038/cr.2016.100.
- Yan H, Luo B, Wu X, Guan F, Yu X, Zhao L, et al. Cisplatin induces pyroptosis via activation of MEG3/NLRP3/caspase-1/GSDMD pathway in triple-negative breast cancer. Int J Biol Sci. 2021;17(10):2606–21. doi:https://doi.org/10.7150/ijbs.60292.
- Kheirandish M, Mahboobi H, Yazdanparast M, Kamal W, Kamal MA. Anti-cancer effects of metformin: recent evidences for its role in prevention and treatment of cancer. Curr Drug Metab. 2018;19(9):793–7. doi:https://doi.org/10.2174/1389200219666180416161846.
- Paixão E, Oliveira A, Pizato N, Muniz-Junqueira MI, Magalhães KG, Nakano EY, Ito MK. The effects of EPA and DHA enriched fish oil on nutritional and immunological markers of treatment naïve breast cancer patients: a randomized double-blind controlled trial. Nutr J. 2017;16(1):71. https://doi.org/10.1186/s12937-017-0295-9.
- Wang H, Zhang H, Wang Y, Brown ZJ, Xia Y, Huang Z, et al. Regulatory T cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis. J Hepatol. 2021;S0168-8278(21)01962-0. Advance online publication. doi:https://doi.org/10.1016/j.jhep.2021.07.032.
- Ernst O, Khan MM, Oyler BL, Yoon SH, Sun J, Lin FY, et al. Species-specific endotoxin stimulus determines toll-like receptor 4- and caspase 11-mediated pathway activation characteristics. mSystems. 2021;6(4):e0030621. https://doi.org/10.1128/mSystems.00306-21.
- Liu M, Lu J, Chen Y, Shi X, Li Y, Yang S, et al. Sodium sulfite-induced mast cell pyroptosis and degranulation. J Agric Food Chem. 2021;69(27):7755–64. doi:https://doi.org/10.1021/acs.jafc.1c02436.
- Wu Z, Li Y, Liu Q, Liu Y, Chen L, Zhao H, et al. Pyroptosis engagement and bladder urothelial cell-derived exosomes recruit mast cells and induce barrier dysfunction of bladder urothelium after uropathogenic E. coli infection. Am J Physiol Cell Physiol. 2019;317(3):C544–C555. doi:https://doi.org/10.1152/ajpcell.00102.2019.